Oral hypoglycemic agents market to reach $75.62 billion by 2030 at 4.9% cagr, driven by rise in type 2 diabetes prevalence.
Read More
Oral contraceptive pills market to reach $61.05 billion by 2030 at 15.0% cagr, driven by rising healthcare expenditure.
Read More
Oral Clinical Nutrition Supplement Market Trends Are Creating New Opportunities For Industry Leaders
Oral clinical nutrition supplement market to reach $18.2 billion by 2030 at 6.6% cagr, driven by growing awareness of preventive healthcare.
Read More
Oral biologics & biosimilars market to reach $24.69 billion by 2030 at 21.6% cagr, driven by rising prevalence of chronic diseases.
Read More
Oral biologics & biosimilar drugs market to reach $17.17 billion by 2030 at 13.3% cagr, driven by rising prevalence of chronic diseases.
Read More
The global oral antidiabetic drugs market to reach $92.64 billion by 2030 at 6.7% cagr, driven by increasing type 2 diabetes.
Read More
The global opioids market to reach $28.59 billion by 2030 at 3.8% cagr, driven by increasing prevalence of chronic diseases.
Read More
Ophthalmic drugs market to reach $61.21 billion by 2030 at 7.9% cagr, driven by increase in the prevalence of ophthalmic disorders.
Read More
Oncology precision medicine market to reach $226.55 billion by 2030 at 12.5% cagr, driven by growing prevalence of cancer.
Read More
Oncology clinical trials market to reach $20.4 billion by 2030 at 6.3% cagr, driven by increasing cancer incidence.
Read More